Literature DB >> 12599288

Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull.

Nancy Lee1, Laura E Millender, David A Larson, William M Wara, Michael W McDermott, Michael J Kaplan, Penny K Sneed.   

Abstract

BACKGROUND: The management of skull base recurrence of salivary gland tumors is challenging, because complete surgical resection and fractionated reirradiation are seldom possible. Experience is being gained with radiosurgery for this indication.
METHODS: From 1994-2000, eight patients with 16 skull base recurrences of salivary gland tumors underwent Gamma Knife radiosurgery at the University of California San Francisco. Local freedom from progression (FFP), regional FFP, locoregional FFP, and survival times were measured from the date of radiosurgery and estimated using the Kaplan-Meier method.
RESULTS: All patients experienced symptomatic response, usually pain resolution. The median local FFP, regional FFP, locoregional FFP, and survival times were 15.4, 12.0, 10.0, and 21.2 months, respectively. The 1-year local FFP probabilities are 93% and 59%, respectively. Local FFP, allowing for salvage radiosurgery, was 100% at 1 year and 75% at 2 years. Five of seven patients with locoregional failure underwent repeat radiosurgery, successfully achieving control for an additional 4.4 to 13.4 months in four patients. One patient had radiation necrosis develop.
CONCLUSION: Radiosurgery provided good local control and symptomatic relief in patients with recurrent salivary gland malignancies involving the base of skull. In patients with good performance status, radiosurgery should be considered as salvage treatment. Copyright 2003 Wiley Periodicals, Inc. Head Neck 25: 210-216, 2003

Entities:  

Mesh:

Year:  2003        PMID: 12599288     DOI: 10.1002/hed.10193

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  Stereotactic radiation therapy for skull base recurrences: Is a salvage approach still possible?

Authors:  Marco Krengli; Giuseppina Apicella; Letizia Deantonio; Marina Paolini; Laura Masini
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-04

2.  Stereotactic Radiation for Palliation of Skull Base Recurrences of Salivary Gland Carcinomas: Implications for Tumor Targeting.

Authors:  Zaid A Siddiqui; Edward Melian; Anil Sethi; Vikram C Prabhu; Iris Rusu; Bahman Emami; John P Leonetti; Douglas E Anderson
Journal:  J Neurol Surg B Skull Base       Date:  2016-07-18

3.  Adenoid cystic carcinoma of the floor of the mouth - A rare presentation.

Authors:  Chandresh Jaiswara; Neeraj Kumar Dhiman; Akhilesh Kumar Singh; Naresh Kumar Sharma; Vishal Verma; Arun Pandey
Journal:  J Oral Biol Craniofac Res       Date:  2015-10-24

Review 4.  The evolving role of stereotactic radiosurgery for patients with skull base tumors.

Authors:  Bruce E Pollock; Robert L Foote
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

5.  Delayed cerebral radiation necrosis after neutron beam radiation of a parotid adenocarcinoma: a case report and review of the literature.

Authors:  Christopher S Hong; Hamza N Gokozan; José J Otero; Michael Guiou; J Bradley Elder
Journal:  Case Rep Neurol Med       Date:  2014-09-30

6.  Full-Thickness Craniodural Metastasis with Leptomeningeal Infiltration of Salivary Origin: A Radiological Lesson and a Technical Remark.

Authors:  Alessandro Pesce; Daniele Armocida; Francesco Fiorentino; Silvia Ciarlo; Biagia La Pira; Maurizio Salvati; Alessandro Frati; Angelo Pompucci; Mauro Palmieri
Journal:  Tomography       Date:  2022-08-27

7.  Reirradiation of recurrent salivary gland malignancies with fractionated stereotactic body radiation therapy.

Authors:  Sana D Karam; James W Snider; Hongkun Wang; Margaux Wooster; Christopher Lominska; John Deeken; Kenneth Newkirk; Bruce Davidson; K William Harter
Journal:  J Radiat Oncol       Date:  2012-02-19

8.  Treatment of malignant tumors of the skull base with multi-session radiosurgery.

Authors:  Nicholas D Coppa; Daniel M S Raper; Ying Zhang; Brian T Collins; K William Harter; Gregory J Gagnon; Sean P Collins; Walter C Jean
Journal:  J Hematol Oncol       Date:  2009-04-02       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.